Introduction to Bone Materials - Mechanics of Cellular Bone Remodeling - page 22

to be investigated efficiently and methodically [29]. However, only a few
mathematical models regarding bone remodeling have thus far been
proposed [8,20,30-36].
References
1. Schoppet M., Preissner K. T., Hofbauer L. C. RANK ligand and osteoprotegerin—
Paracrine regulators of bone metabolism and vascular function. Arteriosclerosis
Thrombosis and Vascular Biology 22 (4): 549-553 (2002).
2. Agata H., Asahina I., Yamazaki Y., Uchida M., Shinohara Y., Honda M. J., Kagami
H., Ueda M. Effective bone engineering with periosteum-derived cells. Journal
of Dental Research 86 (1): 79-83 (2007).
3. Jones S. J., Boyde A. Experimental study of changes in osteoblastic shape
induced by calcitonin and parathyroid extract in an organ-culture system.
Cell and Tissue Research 169 (4): 449-465 (1976).
4. Zallone A. Z., Teti A., Primavera M. V. Resorption of vital or devitalized bone
by isolated osteoclasts in vitro—The role of lining cells. Cell and Tissue Research
235 (3): 561-564 (1984).
5. Chambers T. J., Darby J. A., Fuller K. Mammalian collagenase predisposes
bone surfaces to osteoclastic resorption. Cell and Tissue Research 241 (3): 671-675
(1985).
6. Rodan G. A., Matin T. J. Role of osteoblasts in hormonal control of bone
resorption—A hypothesis. Calcified Tissue International 33 (4): 349-351 (1981).
7. McSheehy P. M. J., Chambers T. J. Osteoblastic cells mediate osteoclastic
responsiveness to parathyroid hormone. Endocrinology 118 (2): 824-828 (1986).
8. Kroll M. Parathyroid hormone temporal effects on bone formation and
resorption. Bulletin of Mathematical Biology 62 (1): 163-188 (2000).
9. Rosenberg A. Skeletal system and soft tissue tumors. In Robbins pathologic
basis of disease, 5th ed., ed. Cotran R. S., Kumar V., Robbins S. L. Philadelphia:
W. B. Saunders Co., pp. 1219-1222 (1994).
10. Pietrzak W. S. Musculoskeletal tissue regeneration: Biological materials and methods.
Totowa, NJ: Humana Press (2008).
11. Kalfas I. H. Principles of bone healing. Neurosurgery Focus 10 (4): 1-4 (2001).
12. Wozney J. M., Rosen V., Celeste A. J., Mitsock L. M., Whitters M. J., Kriz R. W.,
Hewick R. M., Wang E. A. Novel regulators of bone formation—Molecular
clones and activities. Science 242 (4885): 1528-1534 (1988).
13. Poole K., Reeve J. Parathyroid hormone—A bone anabolic and catabolic agent.
Current Opinion in Pharmacology 5 (6): 612-617 (2005).
14. Matt P., Schoenhoff F., Habashi J., Holm T., Van Erp C., Loch D., Carlson O. D.,
et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation
120 (6): 526-532 (2009).
15. Hoch R. V., Soriano P. Roles of PDGF in animal development. Development
130 (20): 4769-4784 (2003).
16. Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth-factor family
of proteins. Annual Review of Biochemistry 58:575-606 (1989).